Cargando…
Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the P(R)EDIGT score
Fifty‐five years after the concept of dopamine replacement therapy was introduced, Parkinson disease (PD) remains an incurable neurological disorder. To date, no disease‐modifying therapeutic has been approved. The inability to predict PD incidence risk in healthy adults is seen as a limitation in d...
Autores principales: | Schlossmacher, Michael G., Tomlinson, Julianna J., Santos, Goncalo, Shutinoski, Bojan, Brown, Earl G., Manuel, Douglas, Mestre, Tiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324667/ https://www.ncbi.nlm.nih.gov/pubmed/27859866 http://dx.doi.org/10.1111/ejn.13476 |
Ejemplares similares
-
Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination
por: Li, Juan, et al.
Publicado: (2022) -
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
por: Tomlinson, Julianna J., et al.
Publicado: (2017) -
Conversations With Dr. Oleh Hornykiewicz, Founding Father of the Dopamine Era in Parkinson's: How Do You Wish to Be Remembered?
por: Schlossmacher, Michael G., et al.
Publicado: (2020) -
The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
por: Mari, Zoltan, et al.
Publicado: (2022) -
Parkin coregulates glutathione metabolism in adult mammalian brain
por: El Kodsi, Daniel N., et al.
Publicado: (2023)